Transparent corporate social responsibility ratings to help you change the world.
LEARN ABOUT A COMPANY'S SUSTAINABILITY
SEARCH BY: TEXT | INDUSTRY | REGION | DATA SOURCE | A–Z

User login form 2012

Profile unified block 2012

PROFILE TOOL
CSRHub user average
EDIT
PRIORITIES
Community
2.6
Employees
2.8
Environment
3.7
Governance
2.9
SPECIAL ISSUES

No special issues for this profile.

SWITCH TO A DIFFERENT PROFILE

Barr Pharmaceuticals, Inc.

This is the basic information on this company, including a description of its business.
Register to see company news
Click here for a list of jobs currently offered by this company.

Generic Pharmaceuticals accounted for 69% of 2006 revenues; Proprietary Pharmaceuticals, 22% & Other, 9%

On July 18, 2008 it was announced that rival firm - Teva Pharmaceutical Industries Ltd, would acquire Barr Pharmaceuticals Inc for $7.46 billion. (Date: March 13, 2010)

Some material on this page has come from non-CSRHub sources.

Ticker:

BRL

ISIN:

US0683061099

Address:

USA, Montvale NJ

Website:

Barr Pharmaceuticals, Inc.

Phone Number:

n/a

CSR Web Area:

Subscriber info

Basic corporate social responsibility ratings

Special issues: none

Data sources for this company

Asset4
Carbon Disclosure Project 2008
Goodness 500
Governance Metrics International
IW Financial
MSCI ESG Intangible Value Assessment
MSCI Global Compact +
Trucost
2 report(s) may be available

Ratings history

 
 

Subcategory CSR ratings

 GovernanceCommunity
BoardLeadership EthicsTransparency & ReportingCommunity Dev & PhilanthropyProductHuman Rights & Supply Chain
Barr Pharmaceuticals, Inc.
Pharmaceutical & Medicine Manufacturing
CSRHub average525248474551
USA
 EmployeesEnvironment
Compensation & BenefitsDiversity & Labor RightsTraining, Health & SafetyEnergy & Climate ChangePolicy & ReportingResource Management
Barr Pharmaceuticals, Inc.
Pharmaceutical & Medicine Manufacturing
CSRHub Average434747444646
USA

Flags

Calvert Social Index
Fortune 1000 list of top companies--2008

Name variants